144 related articles for article (PubMed ID: 35771366)
41. Interpretation of Complete Tumor Response on MRI Following Chemoradiotherapy of Rectal Cancer: Inter-Reader Agreement and Associated Factors in Multi-Center Clinical Practice.
Kim HY; Cho SH; Jang JK; Kim B; Lee CM; Lim JS; Moon SK; Oh SN; Seo N; Park SH
Korean J Radiol; 2024 Apr; 25(4):351-362. PubMed ID: 38528693
[TBL] [Abstract][Full Text] [Related]
42. Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Kim E; Kim K; Kim SH; Han SW; Kim TY; Jeong SY; Park KJ; Koh J; Kang GH; Chie EK
Cancer Res Treat; 2019 Jul; 51(3):1188-1197. PubMed ID: 30590006
[TBL] [Abstract][Full Text] [Related]
43. The role of magnetic resonance tumour regression grade in the prediction of regression and survival of rectal adenocarcinoma after long-course chemoradiotherapy: a cohort study.
Chen HLR; Seow-En I; Chok AY; Ngo NT; Cheng TL; Tan KE
Ann Med Surg (Lond); 2023 Apr; 85(4):842-848. PubMed ID: 37113901
[TBL] [Abstract][Full Text] [Related]
44. Magnetic Resonance Texture Analysis in Identifying Complete Pathological Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer.
Aker M; Ganeshan B; Afaq A; Wan S; Groves AM; Arulampalam T
Dis Colon Rectum; 2019 Feb; 62(2):163-170. PubMed ID: 30451764
[TBL] [Abstract][Full Text] [Related]
45. Carcinoembryonic Antigen Improves the Performance of Magnetic Resonance Imaging in the Prediction of Pathologic Response after Neoadjuvant Chemoradiation for Patients with Rectal Cancer.
Yoo GS; Park HC; Yu JI; Choi DH; Cho WK; Park YS; Park JO; Lim HY; Kang WK; Lee WY; Kim HC; Yun SH; Cho YB; Park YA; Song KD; Kim SH; Ha SY
Cancer Res Treat; 2020 Apr; 52(2):446-454. PubMed ID: 31588705
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of diffusion kurtosis and diffusivity from baseline staging MRI as predictive biomarkers for response to neoadjuvant chemoradiation in locally advanced rectal cancer.
Bates DDB; Mazaheri Y; Lobaugh S; Golia Pernicka JS; Paroder V; Shia J; Zheng J; Capanu M; Petkovska I; Gollub MJ
Abdom Radiol (NY); 2019 Nov; 44(11):3701-3708. PubMed ID: 31154482
[TBL] [Abstract][Full Text] [Related]
47. Predictive value of modified MRI-based split scar sign (mrSSS) score for pathological complete response after neoadjuvant chemoradiotherapy for patients with rectal cancer.
Yuan Y; Zheng K; Zhou L; Chen F; Zhang S; Lu H; Lu J; Shao C; Meng R; Zhang W; Gao X; Shen F
Int J Colorectal Dis; 2023 Feb; 38(1):40. PubMed ID: 36790595
[TBL] [Abstract][Full Text] [Related]
48. [Short-term outcome of programmed cell death protein1 (PD-1) antibody combined with total neoadjuvant chemoradiotherapy in the treatment of locally advanced middle-low rectal cancer with high risk factors].
Li YJ; Zhang L; Dong QS; Cai Y; Zhang YZ; Wang L; Yao YF; Zhang XY; Li ZW; Li YH; Sun YS; Wang WH; Wu AW
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Nov; 24(11):998-1007. PubMed ID: 34823301
[No Abstract] [Full Text] [Related]
49. Radiomics modelling in rectal cancer to predict disease-free survival: evaluation of different approaches.
Tibermacine H; Rouanet P; Sbarra M; Forghani R; Reinhold C; Nougaret S;
Br J Surg; 2021 Oct; 108(10):1243-1250. PubMed ID: 34423347
[TBL] [Abstract][Full Text] [Related]
50. Correlation of Pre- and Post-radio-chemotherapy MRI Texture Features With Tumor Response in Rectal Cancer.
Paiar F; Gabelloni M; Pasqualetti F; Cocuzza P; Montrone S; Arena C; Faggioni L; Falaschi Z; Del Secco L; Alberich-Bayarri A; Bonmati LM; Neri E
Anticancer Res; 2023 Feb; 43(2):781-788. PubMed ID: 36697103
[TBL] [Abstract][Full Text] [Related]
51. Predicting response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer with serum biomarkers.
Clarke TL; White DA; Osborne ME; Shaw AM; Smart NJ; Daniels IR
Ann R Coll Surg Engl; 2017 May; 99(5):373-377. PubMed ID: 28462648
[TBL] [Abstract][Full Text] [Related]
52. MRI and Diffusion-weighted MRI Volumetry for Identification of Complete Tumor Responders After Preoperative Chemoradiotherapy in Patients With Rectal Cancer: A Bi-institutional Validation Study.
Lambregts DM; Rao SX; Sassen S; Martens MH; Heijnen LA; Buijsen J; Sosef M; Beets GL; Vliegen RA; Beets-Tan RG
Ann Surg; 2015 Dec; 262(6):1034-9. PubMed ID: 25211270
[TBL] [Abstract][Full Text] [Related]
53. Rectal Signet Ring Cell Carcinoma: Post-Chemoradiotherapy Evaluation by MRI and Corresponding to Pathology.
Zhou Y; Li Q; Mao Y
Front Surg; 2022; 9():841645. PubMed ID: 35310426
[TBL] [Abstract][Full Text] [Related]
54. [Prognosis and complications of local excision for rectal cancer after neoadjuvant chemoradiotherapy].
Li YH; Qiu XY; Lin GL; Zhou JL; Xiao Y; Qiu HZ
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Apr; 24(4):344-351. PubMed ID: 33878824
[No Abstract] [Full Text] [Related]
55. Response Assessment with MRI after Chemoradiotherapy in Rectal Cancer: Current Evidences.
Seo N; Kim H; Cho MS; Lim JS
Korean J Radiol; 2019 Jul; 20(7):1003-1018. PubMed ID: 31270972
[TBL] [Abstract][Full Text] [Related]
56. Early conformational changes at tumour bed and long term response after neoadjuvant therapy in locally-advanced rectal cancer.
Santiago I; Barata MJ; Figueiredo N; Parés O; Matos C
Eur J Radiol; 2021 Jul; 140():109742. PubMed ID: 33971571
[TBL] [Abstract][Full Text] [Related]
57. Dynamic contrast-enhanced magnetic resonance imaging in locally advanced rectal cancer: role of perfusion parameters in the assessment of response to treatment.
Ciolina M; Caruso D; De Santis D; Zerunian M; Rengo M; Alfieri N; Musio D; De Felice F; Ciardi A; Tombolini V; Laghi A
Radiol Med; 2019 May; 124(5):331-338. PubMed ID: 30560501
[TBL] [Abstract][Full Text] [Related]
58. Comparison of MRI response evaluation methods in rectal cancer: a multicentre and multireader validation study.
El Khababi N; Beets-Tan RGH; Tissier R; Lahaye MJ; Maas M; Curvo-Semedo L; Dresen RC; Nougaret S; Beets GL; Lambregts DMJ;
Eur Radiol; 2023 Jun; 33(6):4367-4377. PubMed ID: 36576549
[TBL] [Abstract][Full Text] [Related]
59. The role of readout-segmented echo-planar imaging-based diffusion-weighted imaging in evaluating tumor response of locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Yang L; Xia C; Liu D; Fang X; Pan X; Ma L; Wu B
Acta Radiol; 2020 Sep; 61(9):1155-1164. PubMed ID: 31924105
[TBL] [Abstract][Full Text] [Related]
60. Utility of ctDNA in predicting response to neoadjuvant chemoradiotherapy and prognosis assessment in locally advanced rectal cancer: A prospective cohort study.
Wang Y; Yang L; Bao H; Fan X; Xia F; Wan J; Shen L; Guan Y; Bao H; Wu X; Xu Y; Shao Y; Sun Y; Tong T; Li X; Xu Y; Cai S; Zhu J; Zhang Z
PLoS Med; 2021 Aug; 18(8):e1003741. PubMed ID: 34464382
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
